Saudi Journal of Kidney Diseases and Transplantation (SJKDT): Table of Contents

Home

About us

Current issue

Instructions

Users online: 2377

Article Cited by others

ORIGINAL ARTICLE

Darbepoetin Use for the Treatment of Anemia in Hemodialysis Patients in Saudi Arabia

Shaheen Faissal A.M, Akeel Nabila, Alfi Adnan, Harbi Ali, Tarif Nauman, Souqiyyeh Mohammad Ziad

Year : 2006| Volume: 17| Issue : 3 | Page no: 365-372

This article has been cited by

1	Monthly administration of darbepoetin alpha in Saudi hemodialysis patients: Is it a practical regimen?

	Alsaran, K. and Sabry, A. and Adulghafour, M. and Hji, M.

	European Journal of General Medicine. 2010; 7(1): 35-42

	[Pubmed] [Google Scholar]

2	The efficacy of monthly administration of darbepoetin alfa in Saudi hemodialysis patients

	Alsaran, K. and Sabry, A. and Abdulghafour, M. and Hji, M.

	Dialysis and Transplantation. 2009; 38(12): 508-513

	[Pubmed] [Google Scholar]

3	A meta-analysis of the relative doses of erythropoiesis-stimulating agents in patients undergoing dialysis

	Bonafont, X. and Bock, A. and Carter, D. and Brunkhorst, R. and Carrera, F. and Iskedjian, M. and Molemans, B. and Dehmel, B. and Robbins, S.

	NDT Plus. 2009; 2(5): 347-353

	[Pubmed] [Google Scholar]

4	Probabilistic cost-minimisation analysis of darbepoetin alpha versus epoetin alpha in treating anaemia secondary to chronic renal failure. Assessment in Spanish clinical practice [AnÃ¡lisis probabilÃstico de minimizaciÃ³n de costes de darbepoetin alfa frente a epoetina alfa en el tratamiento de la anemia secundaria a insuficiencia renal crÃ³nica. ValoraciÃ³n en la prÃ¡ctica clÃnica espaÃ±ola]

	Sanz-Granda, A.

	Farmacia Hospitalaria. 2009; 33(4): 208-216

	[Pubmed] [Google Scholar]

5	Risk factors and potential preventive measures for vascular disease progression in hemodialysis patients

	Tovbin, D. and Ghena, A. and Kormendi, A. and Shnaider, A. and Basok, A. and Zlotnik, M.

	Vascular Disease Prevention. 2007; 4(3): 205-212

	[Pubmed] [Google Scholar]